Transcriptome sequencing and development of an expression microarray platform for liver infection in adenovirus type 5-infected Syrian golden hamsters  by Ying, Baoling et al.
Transcriptome sequencing and development of an expression
microarray platform for liver infection in adenovirus type 5-infected
Syrian golden hamsters
Baoling Ying, Karoly Toth, Jacqueline F. Spencer, Rajeev Aurora, William S.M. Wold n
Saint Louis University School of Medicine, Department of Molecular Microbiology and Immunology, 1100 S. Grand Boulevard, St. Louis, MO 63104,
United States
a r t i c l e i n f o
Article history:
Received 3 June 2015
Returned to author for revisions
3 July 2015
Accepted 30 July 2015
Available online 28 August 2015
Keywords:
Adenovirus
Transcriptome
Syrian hamster
Microarray
Liver
Antiviral response
Innate immunity
a b s t r a c t
The Syrian golden hamster is an attractive animal for research on infectious diseases and other diseases.
We report here the sequencing, assembly, and annotation of the Syrian hamster transcriptome. We
include transcripts from ten pooled tissues from a naïve hamster and one stimulated with lipopoly-
saccharide. Our data set identiﬁed 42,707 non-redundant transcripts, representing 34,191 unique genes.
Based on the transcriptome data, we generated a custom microarray and used this new platform to
investigate the transcriptional response in the Syrian hamster liver following intravenous adenovirus
type 5 (Ad5) infection. We found that Ad5 infection caused a massive change in regulation of liver
transcripts, with robust up-regulation of genes involved in the antiviral response, indicating that the
innate immune response functions in the host defense against Ad5 infection of the liver. The data and
novel platforms developed in this study will facilitate further development of this important
animal model.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The Syrian golden hamster has been used broadly in biomedi-
cal research for decades, especially as a model for cancer devel-
opment. More recently, it has been served as models in research
on diabetes (Bhathena et al., 2011), atherosclerosis (Dillard et al.,
2010; Jove et al., 2013), and neural plasticity (Staffend and Meisel,
2012). Also, the Syrian hamster is frequently employed in studies
of infectious disease, as it is highly susceptible to infection with a
wide range of viruses, bacteria, and parasites (Espitia et al., 2010;
Zivcec et al., 2011). The Syrian hamster has been used to study
emerging and highly pathogenic RNA viral infections and virus-
induced diseases, including ﬂaviviruses (West Nile virus, Japanese
encephalitis virus, St. Louis encephalitis virus, Yellow fever virus),
alphaviruses (Venezuelan-, Western-, Eastern equine encephalitis
virus), henipavirus (Nipah virus), arenaviruses (Pirital virus,
Pichinde virus ), bunyaviruses (Rift valley fever virus, Punta Toro
virus, Andes virus), ﬁloviruses (Ebola virus, Marburg virus), and
SARS-coronavirus (Ebihara et al., 2013; Gowen and Holbrook,
2008; Holbrook and Gowen, 2008; Nakayama and Saijo, 2013;
Roberts et al., 2005). Further, the Syrian hamster has proved to be
a useful model to evaluate vaccines and anti-viral drugs against
both RNA and DNA viruses (Julander et al., 2007, 2011; Monath
et al., 2010; Morrey et al., 2004, 2008; Toth et al., 2008; Wold and
Toth, 2012).
Still further, the Syrian hamster has served as a model to study
human adenovirus (Ad) pathogenesis and to evaluate oncolytic Ad
vectors in cancer gene therapy (Bortolanza et al., 2007; Cerullo
et al., 2012; Dhar et al., 2009a, 2009b, 2012, 2014; Lichtenstein et
al., 2009; Spencer et al., 2009; Thomas et al., 2006, 2007, 2008;
Toth et al., 2007; Wold and Toth, 2012; Ying et al., 2009a; Young et
al., 2013a, 2013b). Human Ads are double-stranded DNA viruses
with a non-enveloped icosahedral capsid. There are approximately
60 types (previously referred to as serotypes) that are classiﬁed
into seven species from A to G (Berk, 2013). In immunocompetent
healthy individuals, most Ad infections are generally mild and self-
limiting, resulting in infections in the upper respiratory tract,
gastrointestinal, and urinary tracts (Wold and Ison, 2013). Some
serotypes can cause serious ocular illness such as epidemic
keratoconjunctinitis. In immunocompromised individuals, espe-
cially in pediatric hematopoietic stem cell transplant patients, Ads
can cause severe disseminated multi-organ infections which are
sometimes lethal (Echavarria, 2008; Ison, 2006; Lion, 2014;
Matthes-Martin et al., 2012, 2013; Sandkovsky et al., 2014; Stercz
et al., 2012; Wold and Ison, 2013).
Syrian hamsters are permissive for human Ads (reviewed in Wold
and Toth (2012)). Ad5 infection following intravenous (i.v.) adminis-
tration results in the hamster's body weight loss, elevated serum liver
enzyme levels, and virus replication in the liver, lungs, and other
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organs (Lichtenstein et al., 2009; Ying et al., 2009). When the hamster
is immunosuppressed using high-dose cyclophosphamide, Ad5 repli-
cation continues for extended periods in multiple organs, especially
the liver, resulting in increased mortality (Thomas et al., 2008; Toth et
al., 2008). This extended replication in hamsters recapitulates human
Ad infection in immunocompromised patients.
A major limitation for using the Syrian hamster as an animal
model for infectious disease is the lack of information on the
hamster genome and its transcription. The Syrian hamster genome
has just been sequenced and released but has not been annotated
(NCBI Bio Project 77669). The transcriptome of Chinese hamster
ovary and Syrian baby hamster kidney cell lines as well as hamster
brain and liver tissue have been analyzed (Johnson et al., 2014;
Schmucki et al., 2013; Vishwanathan et al., 2015). More recently,
the Syrian hamster transcriptome with additional tissues from
brain, lung, spleen, kidney, heart, and liver has been published
(Tchitchek et al., 2014), but the complete global transcriptome
representing whole hamster transcripts, especially genes engaging
in immune responses, has not been documented. Quantitative
reverse transcriptase PCR (qRT-PCR) to detect and quantify some
cytokines and chemokines has been published, but to our knowl-
edge, microarrays speciﬁc to global hamster genes have not been
developed due to the insufﬁciency of genetic data.
We report here the sequencing, assembly, and annotation of
the Syrian hamster whole transcriptome, together with the gen-
eration of hamster microarrays. By using these new platforms, we
describe the ﬁrst global transcriptional analysis of gene expression
in the liver of Ad5-infected Syrian hamsters. Our results provide
unique insights into acute Ad5 infection of the liver, an organ often
infected in disseminated Ad disease in humans.
Results
Hamster transcriptome sequencing and annotation
Our goal was to produce a comprehensive catalog of transcripts
expressed in the adult hamster. To this end, we isolated RNA from
10 organs from a naïve animal and a hamster treated with LPS. The
organs were chosen because they are the targets of many viruses
(e.g. liver) or these organs are complex (e.g. brain) in that they are
composed of many cells types and thus express many genes. LPS
treatment was included to increase the transcription of genes
involved in immune responses, as would be seen in microbiolo-
gical infections. Pooled RNA was subjected to library construction
for deep sequencing.
Illumina HiSeq sequencing produced 5.11010 raw 100 bp
paired-end reads (Table 1). Raw Illumina RNA-Seq data were
adapter trimmed, validated, and ﬁltered based on quality.
Sequences that passed validation and quality checks were
assembled via the de novo RNA-seq assembler Trinity (Grabherr
et al., 2011; Haas et al., 2013). Trinity assembled contigs were
validated via ESTscan and custom software, resulting in a set of
49,176 high-conﬁdence transcripts. These high-conﬁdence tran-
scripts denote the assembled transcriptome. Of the 49,176 tran-
scripts in the assembled transcriptome, 44,705 sequences (91%)
had at least one BLASTP hit, and 30,956 (63%) had at least one
InterProScan hit. The raw reads, as well as the assembled tran-
scripts, have been deposited in GenBank under BioProject ID
PRJNA285471.
Generation of custom hamster microarray and analysis
To assess the genome-wide response to Ad5 infections of the liver,
two groups of hamsters were administered i.v. with either 1010 pfu of
Ad5 or PBS (mock-infection). Ad5 replicates preferentially in the liver
of Syrian hamsters following i.v. administration (Ying et al., 2009).
Liver RNAs were extracted 18 h post-infection (p.i.) and gene expres-
sion was analyzed by a custom designed microarray. Two biological
replicates (independent infections) were performed and each repli-
cate was analyzed in triplicate (Ad5-infected was labeled with Cy3
and mock was labeled with Cy5). A dye-swap experiment was also
performed to correct for any dye bias, for a total of four technical
replicates per biological replicate (one slide). The data were analyzed
using an ANOVA model as previously described (Churchill, 2004;
Kiesel et al., 2007).
A total of 7110 genes in the liver were differentially expressed
with a pr0.01. Of these, 3788 were upregulated and 3322 were
down-regulated in response to Ad5 infection. All signiﬁcantly
differentially expressed genes were further subjected to Gene
Ontology analysis (GO) to identify functional categories of change
in gene expression. As shown in Tables 2A and 2B, transcripts in a
number of critical function categories are over-represented. Most
notably, genes involved in immune response (57 out of 64 genes
(57/64)), defense response to virus (16/17), and antigen processing
and presentation (27/31) were largely upregulated in the liver,
although some were downregulated (Table 2A). Also largely
upregulated were genes associated with regulating DNA-
dependent transcription (82/119), signal transduction (76/109),
cell adhesion (18/18), and cell communication (16/21) (Table 2A).
In contrast, when the most down-regulated genes were investi-
gated for GO function, there was over-representation of genes
associated with oxidation–reduction process (214/249), metabolic
process (82/101), carbohydrate metabolic process (45/69), DNA
topological change (16/21), protein translation (15/18), and tricar-
boxylic acid cycle (7/7) (Table 2B). Differentially regulated genes
are also overrepresented in the GO categories of peptidoglycan
catabolic process and transmembrane transport. In the GO cate-
gory of peptidoglycan catabolic process, 4 genes were upregulated
and 4 genes were downregulated (p value¼1.17e9 ). In the GO
category of transmembrane transport, 11 genes were upregulated
and 12 genes were downregulated (p value¼1.10e08)
Table 3 shows a more detailed depiction of differentially
expressed genes in the GO category of anti-viral responses: 16
out of 17 genes were upregulated, including toll-like receptor
7 and 2, IL-6, and interferon-inducible proteins such as OAS family
members and PKR.
Validation of microarray data by qRT-PCR
To validate the differential gene expression proﬁles obtained by
microarray analysis, qRT-PCR was performed. First, we conﬁrmed the
suitability of four housekeeping genes, namely PPI, RPS6KB1, HBP2,
and GAPDH. These genes range from low, medium–low, medium, and
Table 1
Analysis of transcriptome by RNA-seq.
A. Tissue sampled B. Transcriptome
Blood Total raw read (100bp paired end) 5.11010
Bone Marrow Total number of validated 49,176
Brain Transcripts
Kidney Total number of unique transcripts 42,707
Liver Total number of unique genes 34,191
Cervical lymph node
Lung
Muscle
Spleen
Thymus
A. Each tissue was sampled from two hamsters; one treated with LPS and the
second was untreated. B. Pooled RNA from both hamsters was sequenced on
Illumina HiSeq platform. Summary statistics for raw reads, number of validated
transcripts, unique transcript (eliminating transcripts with alternative start site or
50 end) and total number of genes (based on BLASTP to rat genome).
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high regarding the abundance of their expression, and their expres-
sion was unaffected by Ad5 infection. Therefore, these genes were
appropriate to serve as endogenous controls. We then examined the
relative expression of a few selected target genes which are differen-
tially expressed as found in our microarray analysis. The selected
target genes for validation covered a full expression abundance
spectrum, ranging from low (prostaglandin G/H synthase 1 precursor,
PTGS; 20-50-oligoadenylate synthase 3, OAS3); medium–low (eukar-
yotic translation initiation factor 2 alpha kinase2, PKR); medium
(interferon-inducible protein 10, ICP10; prostaglandin reductase 1,
PTGR1), and high (interferon-induced protein with tetratricopeptide
repeat3-like, IFIT3; MHC-II β chain, MHCIIβ). These selected targets
also represent genes involved in the inﬂamatory response (PTGR1,
PTGS1), the immune response (MHC II), interferon-inducible genes
(IFP10, IFIT3), and interferon-inducible antiviral effector genes
(PKR, OAS3).
The overall results of qRT-PCR were in agreement with the
microarray analysis (Fig. 1); less than two-fold differences were
obtained between the microarray and qRT-PCR data in ﬁve out of
seven genes tested. Two genes (OAS3, IFIT3) showed 8–9 fold
differences between these two types of assays, which probably
reﬂects the intrinsic sensitivity differences between these two
techniques.
The number of Class II Histocompatibility Antigen (MHC II) positive
cells is increased in the liver of Ad5-infected hamsters
To assess whether the increase for the mRNA levels seen for
MHC II translated into increases at the protein levels, we assayed
by ﬂow cytometry single-cell suspensions of livers collected from
mock-infected and Ad5-infected animals. We found that there was
a signiﬁcant elevation in the number of MHC II positive cells in the
liver of Ad5-infected hamsters compared to mock-infected animals
(Fig. 2). The mean ﬂuorescence intensity of the MHC II positive
cells also increased approximately 3-fold. These data indicate that
the elevation in the MHC II mRNA levels detected by the micro-
array and qRT-PCR were a good indication of the actual protein
levels of MHC II in the sample.
Table 2A
Gene Ontology categories with genes largely up-regulated.
GO Category Number # of Genes Up/Down regulated Frac. P value Go term
GO:0006355 119 82/37 2.14 2.20E16 Regulation of transcription, DNA-dependent
GO:0007165 109 76/33 1.96 2.20E16 Signal transcduction
GO:0006955 64 57/7 1.15 2.20E16 Immune response
GO:0019882 31 27/4 0.56 2.20E16 Antigen processing and presentation
GO:0051607 17 16/1 0.31 4.58E16 Defense response to virus
GO:0006952 9 8/1 0.16 8.30E10 Defense response
GO:0007155 18 18/0 0.32 1.16E09 Cell adhesion
GO:0007154 21 16/5 0.38 1.91E08 Cell communication
GO:0016192 20 14/6 0.36 2.45E08 Vesicle-mediated transport
Table 2B
Gene Ontology categories with genes largely down-regulated.
GO Category Number # of Genes Up/Down regulated Frac. P value Go term
GO:0055114 249 35/214 4.47 2.20E16 Oxidation–reduction process
GO:0008152 101 19/82 1.81 2.20E16 Metabolic process
GO:0005975 69 24/45 1.24 2.20E16 Carbohydrate metabolic process
Go:0006265 21 5/16 0.38 2.20E16 DNA topological change
GO:0006418 18 3/15 0.32 3.36E11 tRNA aminoacylation for protein translation
GO:0046854 11 4/7 0.2 4.17E09 Phosphatidylinositol phosphorylation
GO:0048015 10 3/7 0.18 1.43E08 Phosphatidylinositol-mediated signaling
GO:0006099 7 0/7 0.13 1.14E07 Tricarboxylic acid cycle
Table 3
Regulation of genes involved in viral response.
Locus ID Gene Fold change (mean7std. dev.)
locus_03211 Toll-like receptor 7 10.370.197
locus_05992 Toll-like receptor 2 6.570.126
locus_11815 Mitochondrial antiviral-signaling protein-like 1.570.056
locus_06466 20-50-oligoadenylate synthase 2-like 11.970.226
locus_11667 20-50-oligoadenylate synthase 1A-like 11.970.074
locus_11853 59 kDa 20-50-oligoadenylate synthase-like protein-like 4.170.067
locus_16812 20-50-oligoadenylate synthetase 3-like 22.670.146
locus_29063 20-50-oligoadenylate synthetase 3 7.670.174
locus_41602 20-50-oligoadenylate synthase 1-like 23.370.017
locus_41730 20-50-oligoadenylate synthase 3-like 5.370.151
locus_48794 20-50-oligoadenylate synthase 1-like 1.570.033
locus_32403 Interferon-inducible protein 10 35.970.042
locus_15775 Interferon-activable protein 204 22.270.034
locus_25036 IL-6 6.170.104
locus_06991 Antigen-presenting glycoprotein CD1d1-like 6.570.126
locus_23284 Proteoglycan 3-like 6.170.094
locus_11801 Interferon-induced, double-stranded RNA-activated protein kinase 26.570.093
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Discussion
Global transcriptome representing whole Syrian golden hamster
transcripts
In this report, we extend previously described Syrian hamster
transcriptome data (see Introduction) and we provide novel informa-
tion on the pathogenesis of Ad5 in a permissive animal model. We
present the sequence of the hamster transcriptome, the construction
of a unique hamster microarray, and the characterization of the global
transcriptional response in the liver of hamsters to i.v. infection with
Ad5. Our transcriptome covers hamster transcripts derived from ten
pooled tissues. Our study has increased the number of non-redundant
transcripts for the Syrian hamster from 11,648 to 42,707, representing
34,191 unique genes, resulting in 4 increased gene discovery in our
data set. The larger tissue sampling combined with LPS treatment and
deeper sequencing all contributed to the increased gene discovery.
Systemic adenovirus infection causes a massive change in regulation
of the hamster liver transcriptome
Investigations into interactions among Ad and speciﬁc cellular
proteins and pathways in cell culture have provided insights about
Ad and host responses. Genome-wide gene expression analyses have
been performed by several laboratories using different cell lines, cell
culture conditions, cells (non-cancerous versus cancer; proliferating or
quiescent), wild-type Ad, various replication-competent and
replication-defective vectors, and different conditions such as time
post-infection and multiplicity of infection. Several microarray studies
were conducted with Ad5 or the closely related Ad2 in non-cancerous
human cells, namely in IMR-90 cells (a normal diploid cell derived
from lungs of a 16 week female fetus) (Granberg et al., 2006; Stilwell
and Samulski, 2004; Zhao et al., 2007), WI-38 cells (diploid cell line
derived from normal embryonic lung culture) (Rao et al., 2006),
synchronized human foreskin ﬁbroblasts (Miller et al., 2007), or
normal human bronchial epithelial cells (Dorer et al., 2011). Then,
more recently, Ad2-induced transcriptome changes were studied in
detail in IMR-90 cells using a sensitive cDNA deep sequencing strategy
(Zhao et al., 2012). In general, these studies depict a struggle between
the virus and the host cell in which the virus assumes control of the
cell and the cell ﬁghts back with anti-viral defenses. The response
begins within minutes of the virus interacting with the cell receptors
and continues throughout the periods of virus early gene expression,
viral DNA replication and early-late gene expression, and very late
gene expression and virus assembly. Three of the microarray studies
identiﬁed 988 (Zhao et al., 2007), about 2000 (Miller et al., 2007), or
943 (424 up, 519 down) (Dorer et al., 2011) cellular genes that were
differentially up- or down-regulated by a factor of 2, and the RNA
sequencing approach found 3791 genes that were differentially
regulated (Zhao et al., 2012). Of these genes, it’s not clear whether
the changes are caused by the action of the virus directly, e.g. through
the activity of the E1A transcriptional co-regulator, or by the cell
“sensing” that it has been infected. Altogether, these studies revealed
that Ad infection leads to induction of genes involved in cell cycle
regulation (activation), cell proliferation, chromatin reorganization,
DNA replication, RNA transcription and processing, nucleotide meta-
bolism, and theWnt signaling pathway. Some but not all genes whose
promoters contain binding sites for the E2F transcription factor were
conspicuously up-regulated (Miller et al., 2007; Zhao et al., 2012).
When quiescent human foreskin ﬁbroblasts were infected, there was a
reversal of the quiescent state similar to that seen in the cellular
response to serum (Miller et al., 2007). In contrast to the up-regulated
genes, there is repression of genes involved in cell differentiation,
various signaling pathways (TGFβ, Rho, G-protein, Map kinase, STAT,
NFκB), cell death regulation, and metabolism (Dorer et al., 2011; Zhao
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Fig. 1. Validation of Microarray (MA) data of selected genes by qRT-PCR. The mRNA
expression levels of various genes were determined by qRT-PCR to validate the
expression data of the microarray analysis. The fold change represents the mRNA
expression level in Ad5-infected hamsters over that of untreated hamsters. For qRT-
PCR (red bar), the value represents mean7SD of three biological replicates without
pooling RNA. For microarray (MA, black bar), the value represents the average of
two biological replicates.
Fig. 2. The number of MHC II positive cells is elevated in the liver of Ad5-infected hamsters. Combined results from two independent experiments are shown. A, B: Flow
cytometry data from two individual animals. C: The symbols represent data from individual animals, horizontal bars symbolizes the mean, and the whiskers signify the
standard deviation. ** po0.01.
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et al., 2012). Transcriptional activity associated with the p53 transcrip-
tion factor was suppressed (Miller et al., 2007).
Another study in IMR-90 cells employed chromatin immuno-
precipitation combined with microarray (ChIP–chip) technology to
analyze global changes in gene expression at early (6 h), inter-
mediate (12 h), and late times p.i. with h5dl1500, an Ad5 mutant
that expresses only the 243 amino acid (243R) version of E1A
protein (Ferrari et al., 2008), see review by Ferrari et al. (2009).
Interaction of the conserved region 1 (CR1) and conserved region 2
(CR2) domains of the E1A 243R protein with RB family proteins
leads to the release of free E2F family members to activate (or,
with some E2F members, to repress) transcription of target genes.
Also, interaction of the 243R N-terminus with histone acetyltrans-
ferase proteins (p300/CBP) regulates chromatin structure by alter-
ing the global pattern of histone modiﬁcation, in particular
H2K18ac, an epigenetic marker for actively transcribed genes
(Ferrari et al., 2012; Horwitz et al., 2008). Ferrari et al. (2008)
found that transcription of 70% of cellular genes was altered in
cells infected by H5dl1500 and that these changes were linked to
E1A binding to RB members and p300/CBP. In brief, at early times
p.i., E1A caused induction of genes that function in cell cycle
regulation, and at late times (24 h p.i.) E1A activity led to
repression of genes that function in development, differentiation,
and cell signaling. Cell genes involved in defense against virus
infection were induced at 6 h but repressed by 24 h p.i. The results
of Ferrari et al. (2008) are generally consistent with the gene
proﬁling data discussed earlier and they appear to make sense: cell
cycle and DNA replication genes needed by the virus are induced
and antiviral defense genes and cell differentiation genes that are
harmful or not needed by the virus are repressed.
In addition to non-cancerous cell lines, microarray gene proﬁl-
ing studies have been conducted in several cancer cell lines
infected by wild type Ad or Ad vectors, namely HeLa (Granberg
et al., 2005; Zhao et al., 2003), Huh7 (Martina et al., 2007), and
melanoma (Dorer et al., 2011; Volk et al., 2005) cells. In general, in
these cells Ad infection affected genes involved in cell growth
arrest, cell metabolism, and antiviral defense. Interestingly, fewer
genes were dysregulated in cancer cells than in normal cells,
consistent with the idea that infection of normal cells by Ad
induces a cancer cell-like state (Ferrari et al., 2009, 2008; Horwitz
et al., 2008).
A very recent study used microarray technology to examine
cellular transcription in response to induction of the Ad2-coded
E4orf3 protein in cells stably transfected with the gene for E4orf3
(Vink et al., 2015). E4orf3 functions in Ad replication by causing
cellular proteins to re-localize into ﬁlamentous nuclear inclusions
termed “tracks”. Multiple cellular proteins that are re-localized
into these tracks function in the DNA damage response, the
interferon response, and cellular transcription. Upon induction of
E4orf3 in the transfected cells, more than 400 cellular genes were
differentially regulated; 70% of the genes were upregulated and
30% were downregulated. With at least 8 of these genes, dysre-
gulation was linked to nuclear track formation, i.e. physical
relocation of cellular proteins into the tracks (Vink et al., 2015).
Many of the genes with altered expression inﬂuence cellular
growth properties and a variety of the proteins coded by these
genes localize to the extracellular space or plasma membrane.
Some genes affected by E4orf3 are also involved in antiviral
activity.
Microarray based gene expression analysis of Ad-induced tran-
scriptome changes have also been documented in a mouse cell culture
system (mouse embryo ﬁbroblasts, MEFs) as well as in non-permissive
C57BL/6 J mice following systemic infection with a replication-
defective E1- and E3-minus Ad5-based vector (Hartman et al., 2007,
2008). While these studies revealed differences in the expression of
genes belonging to particular function groups, these studies only
analyzed the host transcriptome response in a non-permissive host
for Ad infection, and did not address the role of viral replication and
viral late gene expression in modulating host responses.
As discussed earlier, the liver is the major site of Ad5 replication in
Syrian hamsters following i.v. administration of Ad5 (Lichtenstein
et al., 2009; Thomas et al., 2008; Toth et al., 2008; Ying et al., 2009).
Accordingly, we developed a hamster expression microarray to
investigate the transcriptional response in the liver to systemic Ad5
infection. Our analysis revealed that approximately 16% of total
unique transcripts were differentially expressed, indicating an exten-
sive change in liver transcription. Functional analysis using GO
categories revealed that genes involved in the immune response,
defense response to virus, and antigen processing and presentation
were largely upregulated (Table 2A). The same is true with genes
associated with regulating DNA-dependent transcription, signal trans-
duction, cell adhesion, and cell communication (Table 2A). Cell
adhesion and cell-cell communication are critical in immune
response networks where various lymphocytes, antigen-presenting
cells, and antigen interact actively. Up-regulation of genes in these
categories is further indication of an activated immune response to
virus infection. The most down-regulated genes were associated with
oxidation–reduction process, metabolic process, carbohydrate meta-
bolic process, DNA topological change, protein translation, and
tricarboxylic acid cycle (Tables 2B). Our results are in good agreement
with the microarray analysis of gene expression in the liver of C57BL/
6 J mice infected i.v. with a replication-defective Ad5 vector (Hartman
et al., 2007). The latter study found that up-regulated genes are over-
represented in categories involving the defense response, immune
response, antigen presentation, signal transduction, and RNA proces-
sing, whereas down-regulated genes are over-represented in cate-
gories associated with metabolism, oxidoreduction, chromatin
maintenance, and remodeling.
Robust up-regulation of genes involved in antiviral response
Taking a closer examination of differentially expressed genes
involved in anti-viral responses, receptors engaging in the inﬂamma-
tory immune response such as toll-like receptor 2 and 7 were
upregulated (Table 3). Other genes associated with the inﬂammatory
response such proteoglycan 3 and cytokine IL-6 were also upregu-
lated. Most notably, a cluster of genes including PKR and oligoadeny-
late synthase family members OAS1-3 were upregulated. PKR and
OAS are two major IFN-induced effectors demonstrated to possess
antiviral activities against various viruses through different mechan-
isms of action. Following activation by viral double-stranded RNA
(dsRNA), OAS synthesizes 20,50-oligoadenylates that in turn activate
RNAse L, which in turn triggers cellular and viral RNA cleavage. IFN-
induced PKR, following binding of dsRNA, inhibits cellular and viral
protein translation by phosphorylation of eukaryotic translation
initiation factor 2α (Randall and Goodbourn, 2008; Sadler and
Williams, 2008).
Our data imply that innate immune responses mediated by
activation of toll-like receptors, induction of proinﬂammatory cyto-
kines and IFN pathways provide a ﬁrst line of host defense against
systemic Ad5 in the liver at the early encounter of infection, and that
innate immune responses play a crucial role in controlling virus
infection, likely mediated through the action of Kupffer cells. We have
shown that the number of MHC II positive cells increased in the liver
of Ad5 infected hamsters, and that these cells up-regulate the surface
expression of MHC II, indicating up-regulation of the antigen pre-
sentation process. These ﬂow cytometry data corroborate data
obtained using microarray and qRT-PCR. This elevation in the number
of MHC II positive cells in the liver is somewhat unexpected, inasmuch
as Ad5 is known to preferentially infect and kill Kupffer cells, the major
MHC II positive cell population in the liver, within minutes of
intravenous injection (Smith et al., 2008). Further, the Ad E1 A protein
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down-regulates the expression of MHC II RNA (Kretsovali et al., 1998).
Clearly, further investigation is needed to discover the nature of the
MHC II positive cells in the liver of Ad5-infected hamsters.
In summary, our current study signiﬁcantly expanded the
number of non-redundant transcripts of the Syrian hamster
transcriptome to 42,707, representing 34,191 unique genes, and
generated a microarray platform for global transcription analysis.
By using these new platforms, we describe the ﬁrst global
transcriptional analysis of gene expression in the liver of Ad5-
infected Syrian hamsters. We anticipate that the novel platforms
developed in this study will facilitate further development of new
tools for this important animal model, and will be beneﬁcial to the
whole hamster research community.
Materials and methods
Animals
Female Syrian hamsters (Mesocricetus auratus) were obtained
from Harlan Laboratories, Indianapolis, IN. All studies were
approved by the Institutional Animal Care and Use Committee of
Saint Louis University and were conducted according to federal
and institutional regulations.
RNA extraction
To extract RNA for transcriptome sequencing, two female
Syrian hamsters (5–6 weeks old), one untreated and one treated
intraperitoneally with lipopolysaccharide (LPS) for 18 h, were
anesthetized with CO2 and then sacriﬁced. Whole blood was
collected by cardiac puncture, and bone marrow was ﬂushed from
the femur. Both blood and bone marrow samples were placed into
RNA Protect Animal Blood tubes (Qiagen, Valencia, CA). Eight
different organs were collected and frozen immediately in liquid
nitrogen (Table 1). Total RNAs from blood and bone marrow were
extracted using RNeasy Protect Animal Blood kit (Qiagen). RNA
was extracted from all organs except liver by homogenizing the
samples in Trizol reagent and then extracting the RNA from the
homogenate. To extract liver RNA the sample was homogenized in
RNALater buffer and the homogenate was processed using the
RNeasy mini kit (Qiagen). All RNA samples were treated with
RNase-free DNase followed by RNA cleanup to eliminate DNA
contamination. RNA integrity was determined using a 2100 Bioa-
nalyzer (Agilent Technologies, Santa Clara, CA), while the RNA
yield was determined on a NanoDrop-2000 spectrophotometer. To
obtain a diverse representation of the whole transcriptome, total
RNAs from all the organs were pooled from an untreated and a
LPS-treated hamster (Table 1). The pooled RNA quality, as assessed
by Bioanalyzer (Agilent), had a RNA integrity number (RIN) of 8.5.
To extract RNA for microarray analysis, four female hamsters
were divided into two groups; two hamsters in each group were
administered i.v. with either phosphate buffered saline (PBS) or
1010 plaque forming units (pfu) of Ad5 in a total volume of 200 ml.
Hamsters were sacriﬁced 18 h later and liver RNA from each
hamster was extracted using the RNeasy mini kit.
To extract RNA for microarray validation, two groups of three
hamsters each were treated with PBS or Ad5 i.v. and then liver
RNA was extracted as described as above.
Library construction and sequencing
Approximately 450 ng (quantiﬁed by Qubit; Life Technologies)
of pooled RNA was used as input for library construction.
For sequencing, a library was generated using Illumina TruSeq
RNA preparation kit version 2 following the manufacturer's
directions. The library was sequenced on Illumina HiSeq to obtain
100 base pair (bp) paired-end reads.
Sequence assembly and annotation
Raw Illumina RNAseq data were adapter trimmed, validated,
and ﬁltered based on quality. Quality-passed data were assembled
via the de novo RNA-seq assembler Trinity (Grabherr et al., 2011;
Haas et al., 2013). Trinity assembled contigs were validated via
ESTscan and custom scripts, resulting in a set of 49,176 high-
conﬁdence transcripts. These high-conﬁdence transcripts denote
the assembled transcriptome. Each protein sequence from the
assembled transcriptome was annotated using BLASTP versus the
NCBI/Genbank NR protein database, and using the protein domain/
motif prediction program InterProScan. BLASTP matching against
protein database typically allows for better annotations because
wobble positions and sequencing errors are eliminated in the
alignment. The sequencing and summary statistics are shown in
Table 1.
Microarray design and analysis
While RNA-Seq is likely to replace microarrays eventually,
microarrays are still used because they are highly time and cost-
effective and because methods of normalization and analysis of
data are more robust. In our hands two-color microarrays perform
as well, if not better than RNA-Seq. Therefore, we designed
microarrays based on the hamster transcriptome. The 60-mer
probes were designed using the high-conﬁdence transcripts.
Brieﬂy, each transcript was divided into non-overlapping (contig-
uous) 60 nucleotide oligonucleotide (oligos). We calculated four
parameters for each oligo: uniqueness, sequence complexity, self-
annealing and melting temperature (TM). The uniqueness para-
meter is the binding energy (Allawi and SantaLucia, 1998) calcu-
lated using the sequence of the oligo to the reverse-
complementary sequence and to its closest match identiﬁed by
BLASTN against the high-conﬁdence transcripts. Sequence com-
plexity is calculated using the Ziv and Lempel algorithm (Ziv and
Lempel, 1977). The TM is calculated using equation and parameters
as previously described (Bolton and Mc Carthy, 1962). The
designed probes were submitted to Agilent for printing of the
arrays in the 860K format, where each slide has eight identical
arrays with 61,657 60-mer-oligonucleotide probes.
Quantitative reverse transcriptase RT-PCR (qRT-PCR)
For qRT-PCR, 2 mg of each RNA and 50 pmol of oligo (dT) primer
were used for in vitro reverse transcription (RT) using the High
Capacity cDNA Reverse Transcription kit (ABI, Forster city, CA).
SYBR Green based qPCR was used to speciﬁcally detect target gene
mRNA. The primers were designed using Primer 3 software and
synthesized by Integrated DNA Technologies (Coralville, IA). The
sequence of the primers is shown in Supplementary Table S1. The
PCR was set up in a 20 μl volume containing 1x SYBRs select
master mix (ABI), 250 nM forward and reverse primers, and 2 μl of
the diluted RT template. Quantiﬁcation was done in triplicate for
each sample using an ABI model 7500 genetic analyzer with the
following cycling parameters: 1 cycle at 50 1C for 2 min, 1 cycle at
95 1C for 10 min, followed by 40 cycles of 95 1C for 15 s and 60 1C
for 1 min. Dissociation curve analysis was performed following
PCR to verify the speciﬁcity of the ampliﬁed product.
The data were analyzed using the ΔΔCt method. Four house-
keeping genes were used as endogenous controls for normal-
ization, namely peptidyl-prolyl cis–trans isomerase-like 1 (PPI),
ribosomal protein S6 kinase polypeptide 1 (RPS6KB1), histone-
binding protein RBBP7 isoform2 (HBP2), and glyceraldehyde-3-
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phosphate dehydrogenase (GAPDH). Brieﬂy, the Ct of each target
gene in a treated hamster was ﬁrst normalized to the Ct of the
endogenous control (ΔCt) and then compared to the same
normalized gene in a mock-treated (calibrator) hamster to deter-
mine the ΔΔCt. The ﬁnal value is displayed as the relative fold
change between the Ad5-infected and mock-treated hamsters.
Flow cytometry
Syrian hamsters were mock-infected or infected i.v. with
1.21010 pfu of Ad5 (n¼3 for both groups; the experiment was
repeated once). At 18 h post injection, the animals were sacriﬁced,
and the liver was perfused with PBS. The liver was harvested, and
the left lateral lobe was homogenized by forcing it through a
100 μm cell strainer (Fisher Scientiﬁc, Waltham, MA). The cell
suspensions were washed using PBS. The cells were incubated
with Live/Dead Fixable Aqua cell stain (Life Technologies, Grand
Island, NY), washed twice with FACS buffer (PBS containing 2%
fetal bovine serum), and then re-suspended in FACS buffer con-
taining a 1:2000 dilution of PE-conjugated anti-mouse/rat MHC
class II (I-Ek; clone 14-4-4 S). After 1 h incubation, the cells were
washed twice with PBS, ﬁxed in 2% paraformaldehyde solution for
5 min, washed in PBS, re-suspended in FACS buffer, and analyzed
on a BD FACS LSRII analyzer.
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